Pharma Stock Roundup: ABBV's Deal With RGNX, LLY COVID Drug's Government Order Win

Published on September 17, 2021

AbbVie (ABBV) buys rights to Regenexbio's gene therapy candidate for chronic retinal diseases. Lilly (LLY) will supply additional doses of its COVID-1...

Continue reading on website
Other news

Ryanair (RYAAY) Shares Jump Over 7% on Raised Traffic Forecast

September 17, 2021
With 210 Boeing 737 aircraft set to be delivered in the next five years, Ryanair (RYAAY) raises its five-year traffic growth target to 50%.

7 Low Price-to-Sales Stocks to Buy in the Current Market

September 17, 2021
Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like FL, GIII,...